0001209191-17-025619.txt : 20170405 0001209191-17-025619.hdr.sgml : 20170405 20170405161445 ACCESSION NUMBER: 0001209191-17-025619 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170404 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keuer Thomas A CENTRAL INDEX KEY: 0001290482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22873 FILM NUMBER: 17742739 MAIL ADDRESS: STREET 1: C/O ARCA BIOPHARMA, INC. STREET 2: 11080 CIRCLEPOINT RD, STE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-04 0 0000907654 ARCA biopharma, Inc. ABIO 0001290482 Keuer Thomas A 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 0 1 0 0 Chief Operating Officer Common Stock 2017-04-04 4 S 0 390 2.41 D 14045 D Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan"). Includes (i) remaining 1,222 previously reported shares issued as RSUs under the Plan that vest on 2/27/18, and (ii) remaining 1,207 previously reported shares issued as RSUs under the Plan that vest on 4/2/18, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 11,616 previously reported shares of common stock owned. /s/ Thomas A. Keuer 2017-04-05